Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by CeriBell, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: CeriBell, Inc.’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342574
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Total cost of revenue | 2,159 | 2,517 | 5,531 | 5,001 |
| Gross profit | 25,938 | 18,682 | 49,060 | 36,689 |
| Operating expenses | ||||
| Research and development | 6,747 | 4,852 | 12,908 | 9,098 |
| Sales and marketing | 24,415 | 17,422 | 46,805 | 35,455 |
| General and administrative | 14,757 | 11,360 | 30,073 | 21,295 |
| Total operating expenses | 45,919 | 33,634 | 89,786 | 65,848 |
| Loss from operations | (19,981) | (14,952) | (40,726) | (29,159) |
Item 1. Financial Statements.
FAQ
- What is CeriBell, Inc.'s R&D?
- CeriBell, Inc. (CBLL) reported R&D of $6.75M in Q2 2026.
- How has CeriBell, Inc.'s R&D changed year-over-year?
- CeriBell, Inc.'s R&D increased by 39.1% year-over-year, from $4.85M to $6.75M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about CeriBell, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude